Eton Pharma President and CEO Sean Brynjelsen sells USD 6.19 million in common shares

• Eton Pharmaceuticals President and CEO Sean Brynjelsen sold 100,000 common shares on Aug. 19-20, SEC filing shows.
• Sales prices ranged from USD 60.17 to USD 62.65 per share.
• Post-transaction holdings stood at 961,194 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028651), on August 20, 2026, and is solely responsible for the information contained therein.